TA
ABBV icon

Tectonic Advisors’s AbbVie ABBV Stock Holding History

Tectonic Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.8M Buy
62,682
+4,928
+9% +$1.06M 0.76% 32
2026
Q1 		$12.6M Buy
57,754
+2,411
+4% +$535K 0.66% 46
2025
Q4 		$12.6M Buy
55,343
+1,955
+4% +$445K 0.67% 40
2025
Q3 		$12.4M Buy
53,388
+3,322
+7% +$676K 0.68% 39
2025
Q2 		$9.29M Buy
50,066
+5,662
+13% +$1.05M 0.54% 48
2025
Q1 		$9.3M Buy
44,404
+2,386
+6% +$464K 0.58% 40
2024
Q4 		$7.47M Buy
42,018
+5,693
+16% +$1.05M 0.49% 49
2024
Q3 		$7.17M Buy
36,325
+3,946
+12% +$736K 0.47% 52
2024
Q2 		$5.55M Buy
32,379
+2,458
+8% +$407K 0.4% 52
2024
Q1 		$5.45M Buy
29,921
+1,005
+3% +$173K 0.42% 50
2023
Q4 		$4.48M Buy
28,916
+1,882
+7% +$274K 0.38% 58
2023
Q3 		$4.03M Buy
27,034
+2,542
+10% +$373K 0.38% 57
2023
Q2 		$3.3M Buy
24,492
+3,169
+15% +$465K 0.41% 57
2023
Q1 		$3.4M Buy
21,323
+4,197
+25% +$642K 0.46% 51
2022
Q4 		$2.77M Buy
17,126
+2,994
+21% +$459K 0.43% 50
2022
Q3 		$1.9M Buy
14,132
+2,807
+25% +$403K 0.35% 58
2022
Q2 		$1.73M Buy
11,325
+2,179
+24% +$333K 0.32% 56
2022
Q1 		$1.48M Buy
9,146
+1,161
+15% +$169K 0.26% 66
2021
Q4 		$1.08M Buy
7,985
+3,913
+96% +$462K 0.19% 74
2021
Q3 		$439K Buy
4,072
+1,152
+39% +$132K 0.09% 124
2021
Q2 		$329K Buy
2,920
+468
+19% +$52.7K 0.07% 134
2021
Q1 		$266K Buy
2,452
+586
+31% +$62.7K 0.07% 140
2020
Q4 		$200K Buy
+1,866
New +$179K 0.05% 152

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Tectonic Advisors's ABBV Position: Q2 2026 in Review

Tectonic Advisors increased its AbbVie (ABBV) stake by 8.5% in Q2 2026, buying an estimated $1.06M and bringing the position to 62,682 shares worth $15.8M. The position accounts for 0.76% of the portfolio, ranked #32.

Tectonic Advisors first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. 4,192 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Tectonic Advisors held 62,682 shares of AbbVie worth $15.8M as of Q2 2026.
  • Tectonic Advisors bought 4,928 AbbVie shares in Q2 2026, an estimated $1.06M.
  • AbbVie made up 0.76% of Tectonic Advisors's portfolio in Q2 2026, its #32 holding.
  • Tectonic Advisors first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
  • 4,192 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Tectonic Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.